Clearsight Advises Huron on the Divestiture of its Life Sciences Business to Oliver Wyman
Clearsight Advisors, Inc. is pleased to announce another successful transaction in its Life Sciences Consulting practice. Clearsight served as the exclusive financial advisor to Huron Consulting Group Inc. (“Huron” or the “Company”) (NYSE: HURN) on the divestiture of its life sciences commercial and R&D strategy, pricing and market access strategy business (the “Life Sciences Business”) … Continued